Preparation and in vivo pharmacokinetics of rhGH-loaded PLGA microspheres

References

• Abdul-Fattah AM, Lechuga-Ballesteros D, Kalonia DS, Pikal MJ. 2008. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state. J Pharm Sci. 97:163–184.
   PubMed Web of Science ®Google Scholar
• Cruz-Angeles J, Martinez LM, Videa M. 2015. Application of ATR-FTIR spectroscopy to the study of thermally induced changes in secondary structure of protein molecules in solid state. Biopolymers. 103:574–584.
   PubMed Web of Science ®Google Scholar
• Della Porta G, Nguyen BN, Campardelli R, Reverchon E, Fisher JP. 2015. Synergistic effect of sustained release of growth factors and dynamic culture on osteoblastic differentiation of mesenchymal stem cells. J Biomed Mater Res A. 103:2161–2171.
   PubMed Web of Science ®Google Scholar
• Demchuk E, Mueller T, Oschkinat H, Sebald W, Wade RC. 1994. Receptor binding properties of four-helix-bundle growth factors deduced from electrostatic analysis. Protein Sci. 3:920–935.
   PubMed Web of Science ®Google Scholar
• Dhankar V, Garg G, Dhamija K, Awasthi R. 2014. Preparation, characterization and evaluation of ranitidine hydrochloride-loaded mucoadhesive microspheres. Polim Med. 44:75–81.
   PubMedGoogle Scholar
• Etman M, Farid R, Nada A, Ebian A. 2010. Preparation and evaluation of fast-release mephenamic acid microspheres. J Microencapsul. 27:640–656.
   PubMed Web of Science ®Google Scholar
• Feng L, Qi XR, Zhou XJ, Maitani Y, Wang SC, Jiang Y, Nagai T. 2006. Pharmaceutical and immunological evaluation of a single-dose Hepatitis B vaccine using PLGA microspheres. J Control Release. 112:35–42.
   PubMed Web of Science ®Google Scholar
• Govoni M, Berardi AC, Muscari C, Campardelli R, Bonafe F, Guarnieri C, Reverchon E, Giordano E, Maffulli N, Della Porta G. 2017. An engineered multiphase three-dimensional microenvironment to ensure the controlled delivery of cyclic strain and human growth differentiation factor 5 for the tenogenic commitment of human bone marrow mesenchymal stem cells. Tissue Eng Part A. 23:811–822.
   PubMed Web of Science ®Google Scholar
• Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A. 2009. The effect of formulation variables on the characteristics of insulin-loaded Poly(Lactic-Co-Glycolic Acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Colloid Surface B. 74:340–349.
   PubMed Web of Science ®Google Scholar
• Jalalipour M, Gilani K, Tajerzadeh H, Najafabadi AR, Barghi M. 2008. Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents. Int J Pharm. 352:209–216.
   PubMed Web of Science ®Google Scholar
• Juloski J, Dumancic J, Scepan I, Lauc T, Milasin J, Kaic Z, Dumic M, Babic M. 2016. Growth hormone positive effects on craniofacial complex in Turner syndrome. Arch Oral Biol. 71:10–15.
   PubMed Web of Science ®Google Scholar
• Kemp SF, Frindik JP. 2011. Emerging options in growth hormone therapy: an update. Drug Des Devel Ther. 5:411–419.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kim CW. 2016. Development and characterization of sodium hyaluronate microparticle-based sustained release formulation of recombinant human growth hormone prepared by spray-drying. J Pharm Sci. 105:613–622.
   PubMed Web of Science ®Google Scholar
• Kwak HH, Shim WS, Choi MK, Son MK, Kim YJ, Yang HC, Kim TH, Lee GI, Kim BM, Kang SH, et al. 2009. Development of a sustained-release recombinant human growth hormone formulation. J Control Release. 137:160–165.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Riley G, Johnson O, Cleland JL, Kim N, Charnis M, Bailey L, Duenas E, Shahzamani A, Marian M, et al. 1997. In vivo characterization of sustained-release formulations of human growth hormone. J Pharmacol Exp Ther. 281:1431–1439.
   PubMed Web of Science ®Google Scholar
• Lee JH, Jeong JS, Kim SK, Song J, Lee JY, Baek S, Choi JH. 2016. Preparation of soluble isotopically labeled human growth hormone produced in Escherichia coli. J Chromatogr B Analyt Technol Biomed Life Sci. 1035:16–24.
   PubMed Web of Science ®Google Scholar
• Leo E, Pecquet S, Rojas J, Couvreur P, Fattal E. 1998. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from Poly(Lactide-Co-Glycolide) microspheres prepared by a w/o/w solvent evaporation method. J Microencapsul. 15:421–430.
   PubMed Web of Science ®Google Scholar
• Liao Y, Zhang L, Gao Y, Zhu ZT, Fong H. 2008. Preparation, characterization, and encapsulation/release studies of a composite nanofiber mat electrospun from an emulsion containing poly (lactic-co-glycolic acid). Polymer (Guildf). 49:5294–5299.
   PubMed Web of Science ®Google Scholar
• Maiti S, Dey P, Kaity S, Ray S, Maji S, Sa B. 2009. Investigation on processing variables for the preparation of fluconazole-loaded ethyl cellulose microspheres by modified multiple emulsion technique. AAPS Pharm Sci Tech. 10:703–715.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 3:1377–1397.
   PubMed Web of Science ®Google Scholar
• Mencarelli F, Kiepe D, Leozappa G, Stringini G, Cappa M, Emma F. 2009. Growth hormone treatment started in the first year of life in infants with chronic renal failure. Pediatr Nephrol. 24:1039–1046.
   PubMed Web of Science ®Google Scholar
• Ohtake S, Wang YJ. 2011. Trehalose: current use and future applications. J Pharm Sci. 100:2020–2053.
   PubMed Web of Science ®Google Scholar
• Pandit SS, Patil AT. 2009. Formulation and in vitro evaluation of buoyant controlled release lercanidipine lipospheres. J Microencapsul. 26:635–641.
   PubMed Web of Science ®Google Scholar
• Pirooznia N, Hasannia S, Lotfi AS, Ghanei M. 2012. Encapsulation of Alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases. J Nanobiotechnol.. 10:20.
   PubMed Web of Science ®Google Scholar
• Polgreen LE, Thomas W, Orchard PJ, Whitley CB, Miller BS. 2014. Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2 years in children with Hurler or Hunter syndrome. Mol Genet Metab. 111:101–106.
   PubMed Web of Science ®Google Scholar
• Raben MS. 1958. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab. 18:901–903.
   PubMed Web of Science ®Google Scholar
• Saenger PH, Mejia-Corletto J. 2016. Long-acting growth hormone: an update. Endocr Dev. 30:79–97.
   PubMedGoogle Scholar
• Seo BB, Park MR, Chun C, Lee JY, Song SC. 2011. The biological efficiency and bioavailability of human growth hormone delivered using injectable, ionic, thermosensitive poly(Organophosphazene)-polyethylenimine conjugate hydrogels. Biomaterials. 32:8271–8280.
   PubMed Web of Science ®Google Scholar
• Shinde UP, Moon HJ, Ko DY, Jung BK, Jeong B. 2015. Control of rhGH release profile from PEG-PAF thermogel. Biomacromolecules. 16:1461–1469.
   PubMed Web of Science ®Google Scholar
• Sommer G, Gianinazzi ME, Kuonen R, Bohlius J, l’Allemand D, Hauschild M, Mullis P-E, Kuehni CE. Swiss Society for Paediatric Endocrinology and Diabetology (SGPED). 2015. Health-related quality of life of young adults treated with recombinant human growth hormone during childhood. PLoS One. 10:e0140944.
   PubMedGoogle Scholar
• Wang C, Yu C, Liu J, Teng L, Sun F, Li Y. 2015. Preparation and in vivo evaluation of PCADK/PLGA microspheres for improving stability and efficacy of rhGH. Int J Pharm. 495:924–931.
   PubMedGoogle Scholar
• Wei G, Lu LF, Lu WY. 2007. Stabilization of recombinant human growth hormone against emulsification-induced aggregation by pluronic surfactants during microencapsulation. Int J Pharm. 338:125–132.
   PubMed Web of Science ®Google Scholar
• Wei Y, Wang Y, Kang A, Wang W, Ho SV, Gao J, Ma G, Su Z. 2012. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles. Mol Pharm. 9:2039–2048.
   PubMed Web of Science ®Google Scholar
• Yu ZY, Zhang HY, Zhang H, Zhang Q, Li YZ. 2004. Study on release of recombinant human growth hormone poly lactice-co-glytic acid microspheres in vitro and the effects of additives. Chin Pharm J. 39:608–611.
   Google Scholar
• Zanou N, Gailly P. 2013. Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways. Cell Mol Life Sci. 70:4117–4130.
   PubMed Web of Science ®Google Scholar
• Zhou P, An T, Zhao C, Li Y, Li R, Yang R, Wang Y, Gao X. 2015. Lactosylated PLGA nanoparticles containing – polylysine for the sustained release and liver-targeted delivery of the negatively charged proteins. Int J Pharm. 478:633–643.
   PubMedGoogle Scholar